Polymorphisms in nitric oxide synthase and endothelin genes among children with obstructive sleep apnea

BMC Medical Genomics

Abdelnaby Khalyfa²  Wasana Sukhumsirichart¹  Yang Wang²  Ahamed A Khalyfa²  Rakesh Bhattacharjee²  Leila Kheirandish-Gozal²  David Gozal²  Siriporn Chatsuriyawong¹ 

[1] Department of Biochemistry, Faculty of Medicine, Srinakharinwirot University, Sukhumvit 23, Bangkok 10110, Thailand;Department of Pediatrics, Comer Children's Hospital, Pritzker School of Medicine, Biological Sciences Division, The University of Chicago, 900 E, 57th Street, KCBD, 4112, Chicago, IL 60637, USA

关键词: Polymorphisms;    SNP;    Endothelin (EDN);    Nitric oxide synthase (NOS);    OSA;    Children;   

Others  :  1092245
DOI  :  10.1186/1755-8794-6-29

 received in 2013-05-27, accepted in 2013-08-29,  发布年份 2013

【 摘 要 】

Background

Obstructive sleep apnea (OSA) is associated with adverse and interdependent cognitive and cardiovascular consequences. Increasing evidence suggests that nitric oxide synthase (NOS) and endothelin family (EDN) genes underlie mechanistic aspects of OSA-associated morbidities. We aimed to identify single nucleotide polymorphisms (SNPs) in the NOS family (3 isoforms), and EDN family (3 isoforms) to identify potential associations of these SNPs in children with OSA.

Methods

A pediatric community cohort (ages 5–10 years) enriched for snoring underwent overnight polysomnographic (NPSG) and a fasting morning blood draw. The diagnostic criteria for OSA were an obstructive apnea-hypopnea Index (AHI) >2/h total sleep time (TST), snoring during the night, and a nadir oxyhemoglobin saturation <92%. Control children were defined as non-snoring children with AHI <2/h TST (NOSA). Endothelial function was assessed using a modified post-occlusive hyperemic test. The time to peak reperfusion (Tmax) was considered as the indicator for normal endothelial function (NEF; Tmax<45 sec), or ED (Tmax≥45 sec). Genomic DNA from peripheral blood was extracted and allelic frequencies were assessed for, NOS1 (209 SNPs), NOS2 (122 SNPs), NOS3 (50 SNPs), EDN1 (43 SNPs), EDN2 (48 SNPs), EDN3 (14 SNPs), endothelin receptor A, EDNRA, (27 SNPs), and endothelin receptor B, EDNRB (23 SNPs) using a custom SNPs array. The relative frequencies of NOS-1,-2, and −3, and EDN-1,-2,-3,-EDNRA, and-EDNRB genotypes were evaluated in 608 subjects [128 with OSA, and 480 without OSA (NOSA)]. Furthermore, subjects with OSA were divided into 2 subgroups: OSA with normal endothelial function (OSA-NEF), and OSA with endothelial dysfunction (OSA-ED). Linkage disequilibrium was analyzed using Haploview version 4.2 software.

Results

For NOSA vs. OSA groups, 15 differentially distributed SNPs for NOS1 gene, and 1 SNP for NOS3 emerged, while 4 SNPs for EDN1 and 1 SNP for both EDN2 and EDN3 were identified. However, in the smaller sub-group for whom endothelial function was available, none of the significant SNPs was retained due to lack of statistical power.

Conclusions

Differences in the distribution of polymorphisms among NOS and EDN gene families suggest that these SNPs could play a contributory role in the pathophysiology and risk of OSA-induced cardiovascular morbidity. Thus, analysis of genotype-phenotype interactions in children with OSA may assist in the formulation of categorical risk estimates.

【 授权许可】

   
2013 Chatsuriyawong et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 7.

【 参考文献 】

• [1]Punjabi NM: The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 2008, 5(2):136-143.
• [2]Lumeng JC, Chervin RD: Epidemiology of pediatric obstructive sleep apnea. Proc Am Thorac Soc 2008, 5(2):242-252.
• [3]Vlahandonis A, Walter LM, Horne RS: Does treatment of SDB in children improve cardiovascular outcome? Sleep medicine reviews 2013, 17(1):75-85.
• [4]Gottlieb DJ, Yenokyan G, Newman AB, O'Connor GT, Punjabi NM, Quan SF, Redline S, Resnick HE, Tong EK, Diener-West M, et al.: Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation 2010, 122(4):352-360.
• [5]Gozal D: Morbidity of obstructive sleep apnea in children: facts and theory. Sleep Breath 2001, 5(1):35-42.
• [6]Gozal D, Capdevila OS, Kheirandish-Gozal L: Metabolic alterations and systemic inflammation in obstructive sleep apnea among nonobese and obese prepubertal children. Am J Respir Crit Care Med 2008, 177(10):1142-1149.
• [7]Gozal D, Kheirandish-Gozal L: Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more. Am J Respir Crit Care Med 2008, 177(4):369-375.
• [8]Gozal D, Khalyfa A, Capdevila OS, Kheirandish-Gozal L, Khalyfa AA, Kim J: Cognitive function in prepubertal children with obstructive sleep apnea: a modifying role for NADPH oxidase p22 subunit gene polymorphisms? Antioxid Redox Signal 2012, 16(2):171-177.
• [9]Lurie A: Cardiovascular disorders associated with obstructive sleep apnea. Advances in cardiology 2011, 46:197-266.
• [10]Kohli P, Balachandran JS, Malhotra A: Obstructive sleep apnea and the risk for cardiovascular disease. Current atherosclerosis reports 2011, 13(2):138-146.
• [11]Sánchez-de-la-Torre M: Obstructive sleep apnoea and cardiovascular disease. Lancet Respir Med 2013, 1(1):61-62.
• [12]Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, et al.: Sleep apnea and cardiovascular disease: an American heart association/american college Of cardiology foundation scientific statement from the American heart association council for high blood pressure research professional education committee, council on clinical cardiology, stroke council, and council on cardiovascular nursing. In collaboration with the national heart, lung, and blood institute national center on sleep disorders research (national institutes of health). Circulation 2008, 118(10):1080-1111.
• [13]Kato M, Roberts-Thomson P, Phillips BG, Haynes WG, Winnicki M, Accurso V, Somers VK: Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000, 102(21):2607-2610.
• [14]Gozal D, Kheirandish-Gozal L, Serpero LD, Sans Capdevila O, Dayyat E: Obstructive sleep apnea and endothelial function in school-aged nonobese children: effect of adenotonsillectomy. Circulation 2007, 116(20):2307-2314.
• [15]Bhattacharjee R, Kim J, Alotaibi WH, Kheirandish-Gozal L, Capdevila OS, Gozal D: Endothelial dysfunction in children without hypertension: potential contributions of obesity and obstructive sleep apnea. Chest 2012, 141(3):682-691.
• [16]Alvarez R, Gonzalez P, Batalla A, Reguero JR, Iglesias-Cubero G, Hevia S, Cortina A, Merino E, Gonzalez I, Alvarez V, et al.: Association between the NOS3 (−786 T/C) and the ACE (I/D) DNA genotypes and early coronary artery disease. Nitric Oxide 2001, 5(4):343-348.
• [17]Salazar LA, Hirata MH, Giannini SD, Forti N, Diament J, Lima TM, Hirata RD: Seven DNA polymorphisms at the candidate genes of atherosclerosis in Brazilian women with angiographically documented coronary artery disease. Clin Chim Acta 2000, 300(1–2):139-149.
• [18]Grilo A, Ruiz-Granados ES, Moreno-Rey C, Rivera JM, Ruiz A, Real LM, Saez ME: Genetic analysis of candidate SNPs for metabolic syndrome in obstructive sleep apnea (OSA). Gene 2013, 521(1):150-154.
• [19]Zanchi A, Moczulski DK, Hanna LS, Wantman M, Warram JH, Krolewski AS: Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int 2000, 57(2):405-413.
• [20]Wang XL, Wang J: Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol Genet Metab 2000, 70(4):241-251.
• [21]Zintzaras E, Kitsios G, Stefanidis I: Endothelial NO synthase gene polymorphisms and hypertension: a meta-analysis. Hypertension 2006, 48(4):700-710.
• [22]Prudente S, Morini E, Larmon J, Andreozzi F, Di Pietro N, Nigro A, Gervino EV, Mannino GC, Bacci S, Hauser TH, et al.: The SH2B1 obesity locus is associated with myocardial infarction in diabetic patients and with NO synthase activity in endothelial cells. Atherosclerosis 2011, 219(2):667-672.
• [23]Bohm F, Pernow J: The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovascular res 2007, 76(1):8-18.
• [24]Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T: The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 1989, 86(8):2863-2867.
• [25]Colombo MG, Ciofini E, Paradossi U, Bevilacqua S, Biagini A: ET-1 Lys198Asn and ET(A) receptor H323H polymorphisms in heart failure. A case–control study. Cardiology 2006, 105(4):246-252.
• [26]Herrmann S, Schmidt-Petersen K, Pfeifer J, Perrot A, Bit-Avragim N, Eichhorn C, Dietz R, Kreutz R, Paul M, Osterziel KJ: A polymorphism in the endothelin-A receptor gene predicts survival in patients with idiopathic dilated cardiomyopathy. Eur Heart J 2001, 22(20):1948-1953.
• [27]Telgmann R, Harb BA, Ozcelik C, Perrot A, Schonfelder J, Nonnenmacher A, Brand M, Schmidt-Petersen K, Dietz R, Kreutz R, et al.: The G-231A polymorphism in the endothelin-A receptor gene is associated with lower aortic pressure in patients with dilated cardiomyopathy. Am J Hypertens 2007, 20(1):32-37.
• [28]Li H, Louey JW, Choy KW, Liu DT, Chan WM, Chan YM, Fung NS, Fan BJ, Baum L, Chan JC, et al.: EDN1 Lys198Asn is associated with diabetic retinopathy in type 2 diabetes. Molecular vision 2008, 14:1698-1704.
• [29]Yasuda H, Kamide K, Takiuchi S, Matayoshi T, Hanada H, Kada A, Yang J, Miwa Y, Yoshii M, Horio T, et al.: Association of single nucleotide polymorphisms in endothelin family genes with the progression of atherosclerosis in patients with essential hypertension. J Hum Hypertens 2007, 21(11):883-892.
• [30]Lind L, Syvanen AC, Axelsson T, Lundmark P, Hagg S, Larsson A: Variation in genes in the endothelin pathway and endothelium-dependent and endothelium-independent vasodilation in an elderly population. Acta physiologica 2013, 208(1):88-94.
• [31]Gallek M, Alexander S, Crago E, Sherwood P, Horowitz M, Poloyac S, Conley Y: Endothelin-1 and Endothelin Receptor Gene Variants and Their Association With Negative Outcomes Following Aneurysmal Subarachnoid Hemorrhage. Biological research for nursing; 2012.
• [32]Buck D, Diefenbach K, Penzel T, Malzahn U, Roots I, Fietze I: Genetic polymorphisms in endothelin-receptor-subtype-a-gene as susceptibility factor for obstructive sleep apnea syndrome. Sleep medicine 2010, 11(2):213-217.
• [33]Montgomery-Downs HE, O'Brien LM, Gulliver TE, Gozal D: Polysomnographic characteristics in normal preschool and early school-aged children. Pediatrics 2006, 117(3):741-753.
• [34]Rechtschaffen A, Kales A: A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Washington DC: Government Printing Office, National Institute of Health: Allan Rechtschaffen and Anthony Kales, editors, 1st edn; 1968.
• [35]Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK, Marcus CL, Mehra R, Parthasarathy S, Quan SF, et al.: Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the sleep apnea definitions task force of the American academy of sleep medicine. J Clin Sleep Med 2012, 8(5):597-619.
• [36]National High Blood Pressure Education Program Working Group on High Blood Pressure in C, Adolescents: The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004, 114(2 Suppl 4th Report):555-576.
• [37]Bhattacharjee R, Alotaibi WH, Kheirandish-Gozal L, Capdevila OS, Gozal D: Endothelial dysfunction in obese non-hypertensive children without evidence of sleep disordered breathing. BMC pediatrics 2010, 10:8. BioMed Central Full Text
• [38]Kheirandish-Gozal L, Bhattacharjee R, Kim J, Clair HB, Gozal D: Endothelial progenitor cells and vascular dysfunction in children with obstructive sleep apnea. Am J Respir Crit Care Med 2010, 182(1):92-97.
• [39]Wahlberg E, Olofsson P, Swendenborg J, Fagrell B: Changes in postocclusive reactive hyperaemic values as measured with laser Doppler fluxmetry after infrainguinal arterial reconstructions. Eur J Vasc Endovasc Surg 1995, 9(2):197-203.
• [40]Keating BJ, Tischfield S, Murray SS, Bhangale T, Price TS, Glessner JT, Galver L, Barrett JC, Grant SF, Farlow DN, et al.: Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS One 2008, 3(10):e3583.
• [41]Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods (San Diego, Calif 2001, 25(4):402-408.
• [42]Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, et al.: The structure of haplotype blocks in the human genome. Science 2002, 296(5576):2225-2229.
• [43]Lewontin RC: On measures of gametic disequilibrium. Genetics 1988, 120(3):849-852.
• [44]Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA: Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002, 70(2):425-434.
• [45]Brunner F, Bras-Silva C, Cerdeira AS, Leite-Moreira AF: Cardiovascular endothelins: essential regulators of cardiovascular homeostasis. Pharmacol Ther 2006, 111(2):508-531.
• [46]Valle Jimenez M, Estepa RM, Camacho RM, Estrada RC, Luna FG, Guitarte FB: Endothelial dysfunction is related to insulin resistance and inflammatory biomarker levels in obese prepubertal children. Eur J Endocrinol 2007, 156(4):497-502.
• [47]Khalyfa A, Kheirandish-Gozal L, Capdevila OS, Bhattacharjee R, Gozal D: Macrophage migration inhibitory factor gene polymorphisms and plasma levels in children with obstructive sleep apnea. Pediatr Pulmonol 2012, 47(10):1001-1011.
• [48]Bhushan B, Khalyfa A, Spruyt K, Kheirandish-Gozal L, Capdevila OS, Bhattacharjee R, Kim J, Keating B, Hakonarson H, Gozal D: Fatty-acid binding protein 4 gene polymorphisms and plasma levels in children with obstructive sleep apnea. Sleep medicine 2011, 12(7):666-671.
• [49]Khalyfa A, Serpero LD, Kheirandish-Gozal L, Capdevila OS, Gozal D: TNF-alpha gene polymorphisms and excessive daytime sleepiness in pediatric obstructive sleep apnea. J Pediatr 2011, 158(1):77-82.
• [50]Pierola J, Alemany A, Yanez A, De-la-Pena M, Sanchez-de-la-Torre M, Esquinas C, Perez-Gutierrez C, Burguera B, Barbe F, Barcelo A: NADPH oxidase p22phox polymorphisms and oxidative stress in patients with obstructive sleep apnoea. Respir Med 2011, 105(11):1748-1754.
• [51]Pierola J, Barcelo A, de la Pena M, Barbe F, Soriano JB, Sanchez Armengol A, Martinez C, Agusti A: beta3-Adrenergic receptor Trp64Arg polymorphism and increased body mass index in sleep apnoea. Eur Respir J 2007, 30(4):743-747.
• [52]Zintzaras E: he generalized odds ratio as a measure of genetic risk effect in the analysis and meta-analysis of association studies. Stat Appl Genet Mol Biol 2010, 9:21.
• [53]Zintzaras E, Santos M: Estimating the mode of inheritance in genetic association studies of qualitative traits based on the degree of dominance index. BMC Med Res Methodol 2011, 11:171. BioMed Central Full Text
• [54]Khalyfa A, Capdevila OS, Buazza MO, Serpero LD, Kheirandish-Gozal L, Gozal D: Genome-wide gene expression profiling in children with non-obese obstructive sleep apnea. Sleep medicine 2009, 10(1):75-86.
• [55]Kaparianos A, Sampsonas F, Karkoulias K, Spiropoulos K: Obstructive sleep apnoea syndrome and genes. Neth J Med 2006, 64(8):280-289.
• [56]Atkeson A, Yeh SY, Malhotra A, Jelic S: Endothelial function in obstructive sleep apnea. Prog Cardiovasc Dis 2009, 51(5):351-362.
• [57]Atkeson A, Jelic S: Mechanisms of endothelial dysfunction in obstructive sleep apnea. Vasc Health Risk Manag 2008, 4(6):1327-1335.
• [58]Gozal D: Sleep, sleep disorders and inflammation in children. Sleep med 2009, 10(Suppl 1):S12-16.
• [59]Yue W, Liu H, Zhang J, Zhang X, Wang X, Liu T, Liu P, Hao W: Association study of serotonin transporter gene polymorphisms with obstructive sleep apnea syndrome in Chinese Han population. Sleep 2008, 31(11):1535-1541.
• [60]Riha RL, Brander P, Vennelle M, McArdle N, Kerr SM, Anderson NH, Douglas NJ: Tumour necrosis factor-alpha (−308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome. Physiology Eur Respir J 2005, 26(4):673-678.
• [61]Khalyfa A, Bhushan B, Hegazi M, Kim J, Kheirandish-Gozal L, Bhattacharjee R, Capdevila OS, Gozal D: Fatty-acid binding protein 4 gene variants and childhood obesity: potential implications for insulin sensitivity and CRP levels. Lipids Health Dis 2010, 9:18. BioMed Central Full Text
• [62]Chmielewska I, Molina-Martinez FJ, Massot-Cladera M, Diaz-Navarro R, Martinez-Garcia AB: [Vagal cephalalgia: description of a new case report]. Rev Neurol 2012, 55(6):379-380.
• [63]Mishra HK, Sharma SK, Sreenivas V: Angiotensin-converting enzyme gene polymorphism in north Indian population with obstructive sleep apnea. Sleep Breath 2013, 17(3):1029-1037.
• [64]Bouzigon E, Monier F, Boussaha M, Le Moual N, Huyvaert H, Matran R, Letort S, Bousquet J, Pin I, Lathrop M, et al.: Associations between nitric oxide synthase genes and exhaled NO-related phenotypes according to asthma status. PLoS One 2012, 7(5):e36672.
• [65]Duckworth L, Hsu L, Feng H, Wang J, Sylvester JE, Kissoon N, Sandler E, Lima JJ: Physician-diagnosed asthma and acute chest syndrome: associations with NOS polymorphisms. Pediatr Pulmonol 2007, 42(4):332-338.
• [66]Galecki P, Maes M, Florkowski A, Lewinski A, Galecka E, Bienkiewicz M, Szemraj J: Association between inducible and neuronal nitric oxide synthase polymorphisms and recurrent depressive disorder. J Affect Disord 2011, 129(1–3):175-182.
• [67]Kavya R, Saluja R, Singh S, Dikshit M: Nitric oxide synthase regulation and diversity: implications in Parkinson's disease. Nitric Oxide 2006, 15(4):280-294.
• [68]Zeng Z, Li L, Zhang Z, Li Y, Wei Z, Huang K, He L, Shi Y: A meta-analysis of three polymorphisms in the endothelial nitric oxide synthase gene (NOS3) and their effect on the risk of diabetic nephropathy. Human genetics 2010, 127(4):373-381.
• [69]Manso H, Krug T, Sobral J, Albergaria I, Gaspar G, Ferro JM, Oliveira SA, Vicente AM: Variants within the nitric oxide synthase 1 gene are associated with stroke susceptibility. Atherosclerosis 2012, 220(2):443-448.
• [70]Levin ER: Endothelins. N Engl J Med 1995, 333(6):356-363.
• [71]Kohan DE, Rossi NF, Inscho EW, Pollock DM: Regulation of blood pressure and salt homeostasis by endothelin. Physiol Rev 2011, 91(1):1-77.
• [72]Castro MG, Rodriguez-Pascual F, Magan-Marchal N, Reguero JR, Alonso-Montes C, Moris C, Alvarez V, Lamas S, Coto E: Screening of the endothelin1 gene (EDN1) in a cohort of patients with essential left ventricular hypertrophy. Ann Hum Genet 2007, 71(Pt 5):601-610.
• [73]Zhu G, Carlsen K, Carlsen KH, Lenney W, Silverman M, Whyte MK, Hosking L, Helms P, Roses AD, Hay DW, et al.: Polymorphisms in the endothelin-1 (EDN1) are associated with asthma in two populations. Genes and immunity 2008, 9(1):23-29.
• [74]Amin R, Somers VK, McConnell K, Willging P, Myer C, Sherman M, McPhail G, Morgenthal A, Fenchel M, Bean J, et al.: Activity-adjusted 24-hour ambulatory blood pressure and cardiac remodeling in children with sleep disordered breathing. Hypertension 2008, 51(1):84-91.
• [75]de Frutos S, Caldwell E, Nitta CH, Kanagy NL, Wang J, Wang W, Walker MK, Gonzalez Bosc LV: NFATc3 contributes to intermittent hypoxia-induced arterial remodeling in mice. Am J Physiol Heart Circ Physiol 2010, 299(2):H356-363.
• [76]Ci S, Li H, Song H: [Effects of blood pressure day-nocturnal rhythm and endothelin in patients of sleep apnea syndrome]. Zhonghua Jie He He Hu Xi Za Zhi 1996, 19(4):229-231.
• [77]Saarelainen S, Seppala E, Laasonen K, Hasan J: Circulating endothelin-1 in obstructive sleep apnea. Endothelium 1997, 5(2):115-118.